Patent · US Active

Substituted nicotinamide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease

US9951056B2 · kind B2 · utility

4Cited by

0References

4Claims

0Family size

Assignee

Beijing Innocare Pharma Tech Co., Ltd. · CN

Inventors

Xiangyang Chen · Beijing, CN
Yingxiang Gao · 安丰镇, CN
Chong Liu · Longbeilingcun, CN
Haihong Ni · Shanghai, CN
Mark J. Mulvihill · Melville, US

Key dates

Filing date	Sep 29, 2014
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Sep 29, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula I, as shown below and defined herein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.